ovarian cancer and glutathione PDF) Transferase P1: Potential Therapeutic Target in Glutathione as a Prognostic Biomarker
Glutathione as a Prognostic Biomarker and a Potential Therapeutic Target for Ovarian Cancer International Journal of Oncology Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy Anisomycin has the potential to induce human ovarian cancer stem cell ferroptosis by influencing glutathione metabolism and autophagy signal transduction pathways
Pay in 4 interest-free payments of $5.84 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18



